Zimbabwe has declined a major US health deal worth $367m (£272m) over five years over Washington's demand for sensitive data.
This move was revealed after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson has since explained that the United States was demanding access to health data for scientific study and commercial gain while refused to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued talks to reach a agreement suitable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development comes after a similar case in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral deals to boost transparency and responsibility.
According to reports, 16 African countries have so far signed similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would supply the basic resources for medical research with no assurance that the final treatments would be accessible to our citizens if a future disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining frameworks already established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to continued discussions with our US partners on how future co-operation might be structured in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist since a large portion of the nation's Aids initiatives depended on foreign aid.
"If technical issues arise, such as those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group said.
The halted deal emphasises the continuing challenges between receiving crucial foreign assistance and safeguarding local interests in an ever more data-driven world.